Parkinson's patients advised to seek Deep Brain Stimulation treatment in early stages
People with Parkinson's disease who receive Deep Brain Stimulation (DBS) therapy in the early stages of the condition will benefit from a significant increase in quality of life, a revolutionary study from The New England Journal of Medicine has found.
World-leading neurologist and lead clinician Professor Peter Silburn from the Asia-Pacific Centre for Neuromodulation (APCN), a joint initiative of The University of Queensland (UQ) and St Andrew's Hospital, said the results published today in the medical journal would transform the way we treat people with Parkinson's disease.
"Before the release of this study, a typical patient with Parkinson's disease would need to wait around 10 years or until their motor complications could no longer be treated successfully with medicine alone, before DBS surgery was considered an option," Professor Silburn said.
"This study has confirmed the best medical practice for a person with Parkinson's disease is to perform DBS surgery around 4 to 7 years into the condition, as opposed to waiting until the medications stop working."
Participants in the EARLYSTIM trial had been experiencing symptoms of Parkinson's disease for an average of 7.5 years – about five years less than participants in earlier trials – allowing researchers to test the benefits of DBS therapy when motor fluctuations and dyskinesia are of recent onset and occupational and psychosocial competence is still maintained.
Key findings from these participants two years after receiving DBS therapy include:
- 26 percent improvement in their disease-related quality of life
- 53 percent improvement in motor skills
- 30 percent improvement in activities of daily life (speech, handwriting, dressing and walking)
- 61 percent improvement in levodopa-induced complications (including dyskinesias and motor fluctuations)
- 39 percent reduction in daily levodopa equivalent dosage.
Participants who did not undergo DBS surgery and received the best medical therapy only, experienced no improvement in their quality of life, no change in their motor skills, a 12 percent decline in their ability to perform daily activities, a 13 percent worsening in their levodopa-induced complications and a 21 percent increase in their daily levodopa equivalent dosage at two years.
As one of the world's top five centre's conducting DBS surgery, Professor Silburn said the APCN's responsibility to educate and train people in the delivery of DBS surgery has never been more important and patients should be aware of seeking advice from experienced DBS practitioners only.
"One thing that may hinder this study from being adopted earlier in Australia is that very few neurologists and neurosurgeons have been trained in performing DBS surgery," Professor Silburn said.
"Equally challenging, the results from this study need to filter their way through to referring doctors, including general practitioners and neurologists, so that DBS and referral to a DBS specialist are considered earlier in the course of the disease.
"The APCN has the privilege and responsibility to use education, research, clinical collaborations and outcomes to drive the findings of this study into the field, while advancing our understanding of the human brain and treatment therapies for patients with Parkinson's disease."
Professor Silburn hopes this study will serve as a paradigm shift in the way patients with Parkinson's disease think about their treatment options, dispelling the assumptions about being too old, too young, or too far along in the disease to be suitable for DBS surgery.
"My message to people diagnosed with Parkinson's disease is this- it doesn't matter what age you are, or how far along you are in the disease, you don't have to persist with the drugs, or wait until you're so bad that nothing else helps, before considering DBS surgery," Professor Silburn said.
More information: www.nejm.org/doi/f… eatured_home
Journal reference: New England Journal of Medicine
Provided by University of Queensland
- 'Brain pacemaker' effective for years against Parkinson's disease Jun 20, 2012 | not rated yet | 0
- Less-invasive method of brain stimulation helps patients with Parkinson's disease Oct 16, 2012 | not rated yet | 0
- DBS operation for Parkinson's disease performed inside iMRI Sep 19, 2011 | not rated yet | 0
- Deep brain stimulation effects may last for 10 years in patients with Parkinson's disease Aug 08, 2011 | not rated yet | 0
- Parkinson's treatment shows positive results in clinical testing Jan 11, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Neuroscience May 18, 2013 | 5 / 5 (1) | 0 |
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
Neuroscience May 17, 2013 | 4 / 5 (1) | 0 |
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Neuroscience May 17, 2013 | 3.7 / 5 (3) | 0 |
Neurological disorders can have a devastating impact on the lives of sufferers and their families.
Neuroscience May 17, 2013 | 5 / 5 (1) | 0 |
If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit.
Neuroscience May 16, 2013 | 2 / 5 (2) | 0 |
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
2 hours ago | not rated yet | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
3 hours ago | not rated yet | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
7 hours ago | not rated yet | 0
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
3 hours ago | 5 / 5 (1) | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
3 hours ago | 5 / 5 (1) | 0 |
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
2 hours ago | not rated yet | 0